title: [Allergy to biogenetic human protamine insulin with a marked increase in anti-insulin antibody levels and blood eosinophils].
authors.forename: D
authors.initials: D
authors.lastname: Chenon
authors.forename: M
authors.initials: M
authors.lastname: Fabro
authors.forename: J L
authors.initials: JL
authors.lastname: Richard
authors.forename: Y
authors.initials: Y
authors.lastname: Rimbaud
authors.forename: J
authors.initials: J
authors.lastname: Mirouze
authors.forename: J P
authors.initials: JP
authors.lastname: Blayac
mesh_terms: D000328:Adult; D004342:Drug Hypersensitivity / Q000209:etiology*; D004804:Eosinophils / Q000032:analysis; D005260:Female; D006801:Humans; D007330:Insulin Antibodies / Q000378:metabolism*; D049528:Insulin, Long-Acting / Q000009:adverse effects*; D007958:Leukocyte Count
chemical_list: D007330:Insulin Antibodies; D049528:Insulin, Long-Acting
vernacular_title: Allergie à une insuline humaine biogénétique protaminée, avec une augmentation importante des taux d'anticorps anti-insuline et d'eosinophiles.